Asthma may not be a risk factor for severe COVID-19 in children.
作者信息
Amat Flore, Delaisi Bertrand, Labbé Jean-Philippe, Leonardi Jacques, Houdouin Véronique
机构信息
Faculté de Médecine Saint-Antoine, Institut Pierre Louis d'Epidémiologie et de Santé Publique, UMR_S1136, INSERM, Paris, France; Pediatric Pulmonology and Allergology Department, Hôpital Robert Debré, AP-HP, Paris, France.
SSR Pneumopédiatrique La Guisane, Villard Saint Pancrace, Briançon, France.
出版信息
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2478-2479. doi: 10.1016/j.jaip.2021.03.046. Epub 2021 Apr 20.
Abstract
摘要
相似文献
1
Asthma may not be a risk factor for severe COVID-19 in children.哮喘可能不是儿童重症 COVID-19 的风险因素。
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2478-2479. doi: 10.1016/j.jaip.2021.03.046. Epub 2021 Apr 20.
2
Infection with SARS-CoV-2 among children with asthma: evidence from Global Asthma Network.儿童哮喘患者感染 SARS-CoV-2：来自全球哮喘网络的证据。
Pediatr Allergy Immunol. 2022 Jan;33(1):e13709. doi: 10.1111/pai.13709. Epub 2021 Dec 11.
3
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.新型冠状病毒病 2019 与哮喘、变应性鼻炎：分子机制与宿主-环境相互作用。
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):1-7. doi: 10.1097/ACI.0000000000000699.
4
[Asthma and COVID-19].[哮喘与2019冠状病毒病]
Rev Alerg Mex. 2022;69 Suppl 1:s15-s23. doi: 10.29262/ram.v69iSupl1.1009.
5
Risk factors for bronchiolitis and asthma, and COVID-19 symptoms in young children.幼儿细支气管炎和哮喘的危险因素以及新冠病毒病症状
Pediatr Allergy Immunol. 2021 Feb;32(2):215-218. doi: 10.1111/pai.13436.
6
COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence.COVID-19 风险和结局在接受生物制剂或全身皮质类固醇治疗的成年哮喘患者中的：全国真实世界证据。
J Allergy Clin Immunol. 2021 Aug;148(2):361-367.e13. doi: 10.1016/j.jaci.2021.06.006. Epub 2021 Jun 15.
7
COVID-19 and Pediatric Asthma: Clinical and Management Challenges.新型冠状病毒肺炎与儿童哮喘：临床与管理挑战。
Int J Environ Res Public Health. 2021 Jan 26;18(3):1093. doi: 10.3390/ijerph18031093.
8
Asthma and COVID-19: lessons learned and questions that remain.哮喘与 COVID-19：经验教训与未解之谜
Expert Rev Respir Med. 2021 Nov;15(11):1377-1386. doi: 10.1080/17476348.2021.1985763. Epub 2021 Oct 14.
9
Allergy and asthma in children and adolescents during the COVID outbreak: What we know and how we could prevent allergy and asthma flares.新冠疫情期间儿童和青少年的过敏与哮喘：我们所了解的情况以及预防过敏和哮喘发作的方法。
Allergy. 2020 Sep;75(9):2402-2405. doi: 10.1111/all.14369. Epub 2020 May 28.
10
Prevalence of asthma in hospitalized and non-hospitalized children with COVID-19.新型冠状病毒肺炎住院和非住院儿童的哮喘患病率
J Allergy Clin Immunol Pract. 2021 May;9(5):2077-2079.e2. doi: 10.1016/j.jaip.2021.02.038. Epub 2021 Mar 3.
引用本文的文献
1
Recurrent Infections in Allergic Pediatric Patients: An Immune System Problem? A Narrative Review.过敏性儿科患者的反复感染：是免疫系统问题吗？一篇叙述性综述。
Children (Basel). 2025 Jun 17;12(6):788. doi: 10.3390/children12060788.
2
Postacute Sequelae of SARS-CoV-2 in Children.儿童新型冠状病毒 SARS-CoV-2 的后遗症。
Pediatrics. 2024 Mar 1;153(3). doi: 10.1542/peds.2023-062570.
3
Asthma May Not be a Potential Risk Factor for Severe COVID-19 Illness: A Scoping Review.哮喘可能不是重症 COVID-19 疾病的潜在风险因素：一项范围综述。
Environ Health Insights. 2024 Jan 3;18:11786302231221925. doi: 10.1177/11786302231221925. eCollection 2024.
4
Pre and post-COVID 19 infection pulmonary functions in children with chronic respiratory disease: A case series.慢性呼吸道疾病患儿感染新冠病毒前后的肺功能：病例系列
Respirol Case Rep. 2022 Dec 22;11(1):e01077. doi: 10.1002/rcr2.1077. eCollection 2023 Jan.
5
Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: A statement from the EAACI-section on pediatrics.儿童变态反应性疾病和免疫缺陷，2022 年从 COVID-19 大流行中吸取的教训：EAACI 儿科分会的声明。
Pediatr Allergy Immunol. 2022 Oct;33(10):e13851. doi: 10.1111/pai.13851.
6
Caregiver Experiences Managing Persistent Childhood Asthma During the COVID-19 Pandemic.照顾者在 COVID-19 大流行期间管理持续性儿童哮喘的体验。
Clin Pediatr (Phila). 2022 May;61(4):313-319. doi: 10.1177/00099228211070659. Epub 2022 Feb 10.
7
Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection?儿童的空气过敏原敏感性和过敏性鼻炎是否会导致 COVID-19 感染症状较轻？
Allergy Asthma Proc. 2021 Nov 1;42(6):522-529. doi: 10.2500/aap.2021.42.210087.
8
Allergy and COVID-19.过敏与2019冠状病毒病
Acta Biomed. 2021 Nov 29;92(S7):e2021522. doi: 10.23750/abm.v92iS7.12402.
9
COVID-19-Related Pneumonia in an Adolescent Patient with Allergic Asthma.一名患有过敏性哮喘的青少年患者的新型冠状病毒肺炎相关肺炎
Case Rep Med. 2021 Oct 7;2021:6706218. doi: 10.1155/2021/6706218. eCollection 2021.
本文引用的文献
1
Asthma and COVID-19: review of evidence on risks and management considerations.哮喘与2019冠状病毒病：风险及管理考量的证据综述
BMJ Evid Based Med. 2020 Sep 3. doi: 10.1136/bmjebm-2020-111506.
2
SARS-CoV-2 Pneumonia in Hospitalized Asthmatic Patients Did Not Induce Severe Exacerbation.住院哮喘患者的 SARS-CoV-2 肺炎并未引发严重恶化。
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2600-2607. doi: 10.1016/j.jaip.2020.06.032. Epub 2020 Jun 27.
3
Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden.新冠疫情对儿童哮喘的影响：实践调整和疾病负担。
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2592-2599.e3. doi: 10.1016/j.jaip.2020.06.001. Epub 2020 Jun 17.
4
Asthma and COVID-19 in children: A systematic review and call for data.儿童哮喘与 COVID-19：系统评价及数据呼吁。
Pediatr Pulmonol. 2020 Sep;55(9):2412-2418. doi: 10.1002/ppul.24909. Epub 2020 Jul 6.
5
Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2.呼吸道过敏、哮喘与新型冠状病毒受体血管紧张素转换酶2表达的关联。
J Allergy Clin Immunol. 2020 Jul;146(1):203-206.e3. doi: 10.1016/j.jaci.2020.04.009. Epub 2020 Apr 22.
6
Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19).吸烟上调血管紧张素转换酶2受体：新型冠状病毒SARS-CoV-2（新冠病毒）的潜在粘附位点。
J Clin Med. 2020 Mar 20;9(3):841. doi: 10.3390/jcm9030841.
7
Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells.格隆溴铵、福莫特罗和布地奈德对人鼻和气管上皮细胞原代培养物中冠状病毒HCoV-229E复制及细胞因子产生的抑制作用。
Respir Investig. 2020 May;58(3):155-168. doi: 10.1016/j.resinv.2019.12.005. Epub 2020 Feb 21.
8
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.《世界医学协会赫尔辛基宣言：涉及人类受试者的医学研究伦理原则》
JAMA. 2013 Nov 27;310(20):2191-4. doi: 10.1001/jama.2013.281053.
Zotero 插件